<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">perinatology</journal-id><journal-title-group><journal-title xml:lang="ru">Российский вестник перинатологии и педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1027-4065</issn><issn pub-type="epub">2500-2228</issn><publisher><publisher-name>Ltd. “The National Academy of Pediatric Science and Innovation”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21508/1027-4065-2021-66-1-106-112</article-id><article-id custom-type="elpub" pub-id-type="custom">perinatology-1346</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЙ СЛУЧАЙ</subject></subj-group></article-categories><title-group><article-title>Синдром Донна–Барроу в практике нефролога</article-title><trans-title-group xml:lang="en"><trans-title>Donnai–Barrow syndrome in nephrology practice</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3699-1884</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аксенова</surname><given-names>М. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Aksenova</surname><given-names>M. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Аксенова Марина Евгеньевна – кандидат медицинских наук, ведущий научный сотрудник отдела наследственных и приобретенных болезней почек, врач-нефролог консультативно-диагностического отделения </p><p>125412 Москва, ул. Талдомская, д. 2</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">maksyonova@pedklin.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8166-2449</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зайкова</surname><given-names>Н. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Zaikova</surname><given-names>N. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зайкова Наталия Михайловна – кандидат медицинских наук, врач-нефролог отдела наследственных и приобретенных болезней почек </p><p>125412 Москва, ул. Талдомская, д. 2</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">zaikovan@pedklin.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2967-5530</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лепаева</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lepaeva</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лепаева Татьяна Викторовна – кандидат медицинских наук, врач-нефролог отдела наследственных и приобретенных болезней почек </p><p>125412 Москва, ул. Талдомская, д. 2</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3050-7748</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Длин</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Dlin</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Длин Владимир Викторович – доктор медицинских наук, и.о. дир., руководитель отдела наследственных и приобретенных болезней почек им. профессора М.С. Игнатовой </p><p>125412 Москва, ул. Талдомская, д. 2</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ОСП «Научно-исследовательский клинический институт педиатрии им. академика Ю.Е. Вельтищева» ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>29</day><month>03</month><year>2021</year></pub-date><volume>66</volume><issue>1</issue><fpage>106</fpage><lpage>112</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ltd. “The National Academy of Pediatric Science and Innovation”, 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><copyright-holder xml:lang="en">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><license xlink:href="https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.ped-perinatology.ru/jour/article/view/1346">https://www.ped-perinatology.ru/jour/article/view/1346</self-uri><abstract><p>.</p><p>Cиндром Донна–Барроу – мультисистемное заболевание, характеризующееся вариабельным сочетанием врожденных пороков развития, прогрессирующей миопии, нейросенсорной тугоухости, нарушения интеллекта и патологии почек. В статье представлены собственные клинические наблюдения за детьми с синдромом Донна–Барроу, имевшими разный фенотип заболевания, в том числе разные варианты патологии почек. В одном случае пациент имел изолированную низкомолекулярную протеинурию, во втором – протеинурию, гиперкальциурию, нефрокальциноз. Нарушение опосредованного мегалином эндоцитоза, ретроградного эндосомального транспорта лигандов, дисфункция митохондрий, стресс эндоплазматического ретикулума могут приводить к разному спектру и разной степени выраженности тубулярной дисфункции при синдроме Донна–Барроу. Разнообразие клинических проявлений заболевания может обусловливать низкую диагностику синдрома Донна–Барроу и неадекватное ведение пациентов.</p></abstract><trans-abstract xml:lang="en"><p>Donnai–Barrow syndrome is a multi-system disorder characterized by a variable combination of congenital anomalies, progressive myopia, sensorineural hearing loss, intellectual disability and renal disease. The article describes clinical cases of children with different phenotypes of the syndrome, including different renal disorders. One patient had isolated low-molecular-weight proteinuria, another patient suffered from proteinuria, hypercalciuria, nephrocalcinosis. Disruption of megaline-mediated endocytosis, retrograde endosomal transport of ligands, mitochondrial dysfunction, stress of the endoplasmic reticulum can lead to a different spectrum and various degrees of severity of tubular dysfunction in Donnai-Barrow syndrome. A variety of clinical manifestations of the disease can lead to a low diagnosis of Donnai-Barrow syndrome and inadequate patient management.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>синдром Донна–Барроу</kwd><kwd>мегалин</kwd><kwd>миопия</kwd><kwd>синдром Фанкони</kwd><kwd>низкомолекулярная протеинурия</kwd><kwd>гиперкальциурия</kwd><kwd>нефрокальциноз</kwd><kwd>Дент-подобная тубулопатия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>Donnai–Barrow syndrome</kwd><kwd>megalin</kwd><kwd>myopia</kwd><kwd>Fanconi syndrome</kwd><kwd>low molecular weight proteinuria</kwd><kwd>hypercalciuria</kwd><kwd>nephrocalcinosis</kwd><kwd>Dent-like tubulopathy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Marzolo M.P., Farfán P. New insights into the roles of megalin/LRP2 and the regulation of its functional expression. Biol Res 2011; 44(1): 189–105. DOI: 10.4067/S071697602011000100012</mixed-citation><mixed-citation xml:lang="en">Marzolo M.P., Farfán P. New insights into the roles of megalin/LRP2 and the regulation of its functional expression. Biol Res 2011; 44(1): 189–105. DOI: 10.4067/S071697602011000100012</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">De S., Kuwahara S., Saito A. The endocytic receptor megalin and its associated proteins in proximal tubule epithelial cells. Membranes 2014; 4(3): 333–355. DOI: 10.3390/membranes4030333</mixed-citation><mixed-citation xml:lang="en">De S., Kuwahara S., Saito A. The endocytic receptor megalin and its associated proteins in proximal tubule epithelial cells. Membranes 2014; 4(3): 333–355. DOI: 10.3390/membranes4030333</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Fisher C.E., Howie S.E.M. The role of megalin (LRP-2/Gp330) during development. Dev Biol 2006; 296(2): 279– 297. DOI: 10.1016/j.ydbio.2006.06.007</mixed-citation><mixed-citation xml:lang="en">Fisher C.E., Howie S.E.M. The role of megalin (LRP-2/Gp330) during development. Dev Biol 2006; 296(2): 279– 297. DOI: 10.1016/j.ydbio.2006.06.007</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Christ A., Herzog K., Willnow T.E. LRP2, an auxiliary receptor that controls sonic hedgehog signaling in development and disease. Dev Dyn 2016; 245(5): 569–579. DOI: 10.1002/dvdy.24394</mixed-citation><mixed-citation xml:lang="en">Christ A., Herzog K., Willnow T.E. LRP2, an auxiliary receptor that controls sonic hedgehog signaling in development and disease. Dev Dyn 2016; 245(5): 569–579. DOI: 10.1002/dvdy.24394</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Baardman M.E., Zwier M.V., Wisse L.J., Gittenberger-de Groot A.C., Kerstjens-Frederikse W.S., Hofstra R.M.W. et al. Common arterial trunk and ventricular non-compaction in Lrp2 knockout mice indicate a crucial role of LRP2 in cardiac development. Disease Models &amp; Mechanisms 2016; 9: 413–42. DOI: 10.1242/dmm.022053</mixed-citation><mixed-citation xml:lang="en">Baardman M.E., Zwier M.V., Wisse L.J., Gittenberger-de Groot A.C., Kerstjens-Frederikse W.S., Hofstra R.M.W. et al. Common arterial trunk and ventricular non-compaction in Lrp2 knockout mice indicate a crucial role of LRP2 in cardiac development. Disease Models &amp; Mechanisms 2016; 9: 413–42. DOI: 10.1242/dmm.022053</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Storm T., Heegaard S., Christensen E.I., Nielsen R. Megalin deficiency causes high myopia, retinal pigment epithelium-macromelanosomes and abnormal development of the ciliary body in mice. Cell Tissue Res 2014; 358(1): 99–107. DOI: 10.1007/s00441-014-1919-4</mixed-citation><mixed-citation xml:lang="en">Storm T., Heegaard S., Christensen E.I., Nielsen R. Megalin deficiency causes high myopia, retinal pigment epithelium-macromelanosomes and abnormal development of the ciliary body in mice. Cell Tissue Res 2014; 358(1): 99–107. DOI: 10.1007/s00441-014-1919-4</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Cases O., Joseph A., Obry A., Santin M.D., Ben-Yacoub S., Pâques M. et al. Foxg1-Cre mediated Lrp2 inactivation in the developing mouse neural retina, ciliary and retinal pigment epithelia models congenital high myopia. PLoS One 2015; 10: e0129518. DOI: 10.1371/journal.pone.0129518</mixed-citation><mixed-citation xml:lang="en">Cases O., Joseph A., Obry A., Santin M.D., Ben-Yacoub S., Pâques M. et al. Foxg1-Cre mediated Lrp2 inactivation in the developing mouse neural retina, ciliary and retinal pigment epithelia models congenital high myopia. PLoS One 2015; 10: e0129518. DOI: 10.1371/journal.pone.0129518</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Greer J., Babiuk R., Thebaud B. Etiology of Congenital Diaphragmatic Hernia: The Retinoid Hypothesis. Pediatr Res 2003; 53(5): 726–730. DOI: 10.1203/01.PDR.0000062660.12769.E6</mixed-citation><mixed-citation xml:lang="en">Greer J., Babiuk R., Thebaud B. Etiology of Congenital Diaphragmatic Hernia: The Retinoid Hypothesis. Pediatr Res 2003; 53(5): 726–730. DOI: 10.1203/01.PDR.0000062660.12769.E6</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Wynn Y., Yu L., Chung W.K. Genetic causes of congenital diaphragmatic hernia. Semin Fetal Neonatal Med 2014; 19(6): 324–330. DOI: 10.1016/j.siny.2014.09.003.</mixed-citation><mixed-citation xml:lang="en">Wynn Y., Yu L., Chung W.K. Genetic causes of congenital diaphragmatic hernia. Semin Fetal Neonatal Med 2014; 19(6): 324–330. DOI: 10.1016/j.siny.2014.09.003.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Tedja M.S., Haarman A.E.G., Meester-Smoor M.A., Verhoeven V.J.M., Klaver C.C.W., MacGregor S. The Genetics of Myopia. In: M. Ang, T. Wong (eds). Updates on Myopia. Springer, Singapore, 2020. DOI: 10.1007/978-981-13-8491-2_5</mixed-citation><mixed-citation xml:lang="en">Tedja M.S., Haarman A.E.G., Meester-Smoor M.A., Verhoeven V.J.M., Klaver C.C.W., MacGregor S. The Genetics of Myopia. In: M. Ang, T. Wong (eds). Updates on Myopia. Springer, Singapore, 2020. DOI: 10.1007/978-981-13-8491-2_5</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Chassaing N., Lacombe D., Carles D., Calvas P., Saura R., Bieth E. Donnai-Barrow syndrome: four additional patients. Am J Med Genet A 2003; 121A(3): 258–262. DOI: 10.1002/ajmg.a.20266</mixed-citation><mixed-citation xml:lang="en">Chassaing N., Lacombe D., Carles D., Calvas P., Saura R., Bieth E. Donnai-Barrow syndrome: four additional patients. Am J Med Genet A 2003; 121A(3): 258–262. DOI: 10.1002/ajmg.a.20266</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Khalifa O., Al-Sahlawi Z., Imtiaz F., Ramzan K., Allam R., Al-Mostafa A. et al. Variable expression pattern in Donnai-Barrow syndrome: report of two novel LRP2 mutations and review of the literature. Eur J Med Genet 2015; 58(5): 293–299. DOI: 10.1016/j.ejmg.2014.12.008</mixed-citation><mixed-citation xml:lang="en">Khalifa O., Al-Sahlawi Z., Imtiaz F., Ramzan K., Allam R., Al-Mostafa A. et al. Variable expression pattern in Donnai-Barrow syndrome: report of two novel LRP2 mutations and review of the literature. Eur J Med Genet 2015; 58(5): 293–299. DOI: 10.1016/j.ejmg.2014.12.008</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Pober B.R., Longoni M., Noonan K.M. A review of Donnai-Barrow and facio-oculo-acoustico-renal (DB/FOAR) syndrome: clinical features and differential diagnosis. Birth Defects Res A Clin Mol Teratol 2009; 85(7): 76–81. DOI: 10.1002/bdra.20534</mixed-citation><mixed-citation xml:lang="en">Pober B.R., Longoni M., Noonan K.M. A review of Donnai-Barrow and facio-oculo-acoustico-renal (DB/FOAR) syndrome: clinical features and differential diagnosis. Birth Defects Res A Clin Mol Teratol 2009; 85(7): 76–81. DOI: 10.1002/bdra.20534</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Schrauwen I., Sommen M., Claes C., Pinner J., Flaherty M., Collins F., Van Camp G. Broadening the phenotype of LRP2 mutations: A new mutation in LRP2 causes a predominantly ocular phenotype suggestive of Stickler syndrome. Clin Genet 2014; 86(3): 282–286. DOI: 10.1111/cge.12265</mixed-citation><mixed-citation xml:lang="en">Schrauwen I., Sommen M., Claes C., Pinner J., Flaherty M., Collins F., Van Camp G. Broadening the phenotype of LRP2 mutations: A new mutation in LRP2 causes a predominantly ocular phenotype suggestive of Stickler syndrome. Clin Genet 2014; 86(3): 282–286. DOI: 10.1111/cge.12265</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Dachy A., Paquot F., Debray G., Bovy C., Christensen E.I., Collard L., Jouret F. In-depth phenotyping of a Donnai–Barrow patient helps clarify proximal tubule dysfunction. Pediatr Nephrol 2015; 30(3):1027–1031. DOI:10.1007/s00467014-3037-7</mixed-citation><mixed-citation xml:lang="en">Dachy A., Paquot F., Debray G., Bovy C., Christensen E.I., Collard L., Jouret F. In-depth phenotyping of a Donnai–Barrow patient helps clarify proximal tubule dysfunction. Pediatr Nephrol 2015; 30(3):1027–1031. DOI:10.1007/s00467014-3037-7</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kantarci S., Al-Gazali L., Hill R.S., Donnai D., Black G.C.M., Bieth E. et al. Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes. Nat Genet 2007; 39(8): 957– 959. DOI: 10.1038/ng2063</mixed-citation><mixed-citation xml:lang="en">Kantarci S., Al-Gazali L., Hill R.S., Donnai D., Black G.C.M., Bieth E. et al. Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes. Nat Genet 2007; 39(8): 957– 959. DOI: 10.1038/ng2063</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Anglani F., Terrin L., Brugnara M., Battista M., Cantaluppi V., Ceol M. et al. Hypercalciuria and nephrolithiasis: expanding the renal phenotype of Donnai-Barrow syndrome. Clin Genet 2018; 94(1): 187–188. DOI: 10.1111/cge.13242</mixed-citation><mixed-citation xml:lang="en">Anglani F., Terrin L., Brugnara M., Battista M., Cantaluppi V., Ceol M. et al. Hypercalciuria and nephrolithiasis: expanding the renal phenotype of Donnai-Barrow syndrome. Clin Genet 2018; 94(1): 187–188. DOI: 10.1111/cge.13242</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Flemming J., Marczenke M., Rudolph I.M., Nielsen R., Storm T., Erik I.C. et al. Induced pluripotent stem cell-based disease modeling identifies ligand-induced decay of megalin as a cause of Donnai-Barrow syndrome. Kidney Int 2020; 98(1): 159–167. DOI: 10.1016/j.kint.2020.02.021</mixed-citation><mixed-citation xml:lang="en">Flemming J., Marczenke M., Rudolph I.M., Nielsen R., Storm T., Erik I.C. et al. Induced pluripotent stem cell-based disease modeling identifies ligand-induced decay of megalin as a cause of Donnai-Barrow syndrome. Kidney Int 2020; 98(1): 159–167. DOI: 10.1016/j.kint.2020.02.021</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Shaheen I.S., Finlay E., Prescott K., Russell M., Longoni M., Joss S. Focal segmental glomerulosclerosis in a female patient with Donnai–Barrow syndrome. Clin Dysmorphol 2010; 19(1): 35–37. DOI: 10.1097/MCD.0b013e328333c20a</mixed-citation><mixed-citation xml:lang="en">Shaheen I.S., Finlay E., Prescott K., Russell M., Longoni M., Joss S. Focal segmental glomerulosclerosis in a female patient with Donnai–Barrow syndrome. Clin Dysmorphol 2010; 19(1): 35–37. DOI: 10.1097/MCD.0b013e328333c20a</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Storm T., Tranebj rg L., Frykholm C., Birn H., Verroust P.J., Nevéus T. et al. Renal phenotypic investigations of megalin-deficient patients: novel insights into tubular proteinuria and albumin filtration. Nephrol Dial Transplant 2013; 28(3): 585–591. DOI: 10.1093/ndt/gfs462</mixed-citation><mixed-citation xml:lang="en">Storm T., Tranebj rg L., Frykholm C., Birn H., Verroust P.J., Nevéus T. et al. Renal phenotypic investigations of megalin-deficient patients: novel insights into tubular proteinuria and albumin filtration. Nephrol Dial Transplant 2013; 28(3): 585–591. DOI: 10.1093/ndt/gfs462</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Yoshida H. ER stress and diseases. FEBS J 2007; 274(3): 630– 658. DOI: 10.1111/j.1742-4658.2007.05639.x</mixed-citation><mixed-citation xml:lang="en">Yoshida H. ER stress and diseases. FEBS J 2007; 274(3): 630– 658. DOI: 10.1111/j.1742-4658.2007.05639.x</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Li Q., Lei F., Tang Y., Pan J.S., Tong Q., Sun Y., Sheikh-Hamad D. Megalin mediates plasma membrane to mitochondria cross-talk and regulates mitochondrial metabolism. Cell Mol Life Sci 2018; 75(21): 4021–4040. DOI: 10.1007/s00018018-2847-3</mixed-citation><mixed-citation xml:lang="en">Li Q., Lei F., Tang Y., Pan J.S., Tong Q., Sun Y., Sheikh-Hamad D. Megalin mediates plasma membrane to mitochondria cross-talk and regulates mitochondrial metabolism. Cell Mol Life Sci 2018; 75(21): 4021–4040. DOI: 10.1007/s00018018-2847-3</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Johannes L., Popoff V. Tracing the retrograde route in protein trafficking. Cell 2008; 135(7): 1175–1187. DOI: 10.1016/j.cell.2008.12.009</mixed-citation><mixed-citation xml:lang="en">Johannes L., Popoff V. Tracing the retrograde route in protein trafficking. Cell 2008; 135(7): 1175–1187. DOI: 10.1016/j.cell.2008.12.009</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Nielsen R., Courtoy P.J., Jacobsen C., Dom G., Lima W.R., Jadot M. et al. Endocytosis provides a major alternative pathway for lysosomal biogenesis in kidney proximal tubular cells. Proc Natl Acad Sci U S A 2007; 104(13): 5407–5412. DOI: 10.1073/pnas.0700330104</mixed-citation><mixed-citation xml:lang="en">Nielsen R., Courtoy P.J., Jacobsen C., Dom G., Lima W.R., Jadot M. et al. Endocytosis provides a major alternative pathway for lysosomal biogenesis in kidney proximal tubular cells. Proc Natl Acad Sci U S A 2007; 104(13): 5407–5412. DOI: 10.1073/pnas.0700330104</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Anglani F., Gianesello L., Beara-Lasic L., Lieske J. Dent disease: A window into calcium and phosphate transport. J Cell Mol Med 2019; 23(11): 7132–7142. DOI: 10.1111/jcmm.14590</mixed-citation><mixed-citation xml:lang="en">Anglani F., Gianesello L., Beara-Lasic L., Lieske J. Dent disease: A window into calcium and phosphate transport. J Cell Mol Med 2019; 23(11): 7132–7142. DOI: 10.1111/jcmm.14590</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Patrie K.M., Drescher A.J., Welihinda A., Mundel P., Margolis B. Interaction of two actin-binding proteins, synaptopodin and alpha-actinin-4, with the tight junction protein MAGI-1. J Biol Chem 2002; 277(33): 30183–30190. DOI: 10.1074/jbc.M203072200</mixed-citation><mixed-citation xml:lang="en">Patrie K.M., Drescher A.J., Welihinda A., Mundel P., Margolis B. Interaction of two actin-binding proteins, synaptopodin and alpha-actinin-4, with the tight junction protein MAGI-1. J Biol Chem 2002; 277(33): 30183–30190. DOI: 10.1074/jbc.M203072200</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Stora S., Conte M., Chouery E., Richa S., Jalkh N., Gillart A.C. et al. A 56-year-old female patient with facio-oculo-acoustico-renal syndrome (FOAR) syndrome. Report on the natural history and of a novel mutation. Eur J Med Genet 2009; 52(5): 341–343. DOI: 10.1016/j.ejmg.2009.06.005</mixed-citation><mixed-citation xml:lang="en">Stora S., Conte M., Chouery E., Richa S., Jalkh N., Gillart A.C. et al. A 56-year-old female patient with facio-oculo-acoustico-renal syndrome (FOAR) syndrome. Report on the natural history and of a novel mutation. Eur J Med Genet 2009; 52(5): 341–343. DOI: 10.1016/j.ejmg.2009.06.005</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
